IP Verse

Buprenorphine Dosing Regimens

Patent No. EP3215223 (titled "Buprenorphine Dosing Regimens") was filed by Indivior UK on Nov 6, 2015. The application was issued on Jul 1, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ELKINGTON AND FIFEMar 30, 2021ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3215223

INDIVIOR UK
Application Number
EP15828368A
Filing Date
Nov 6, 2015
Status
Granted And Under Opposition
May 29, 2020
Publication Date
Jul 1, 2020
External Links
Slate, Register , Google Patents